Special coverage: Retroviruses Conference 2006. Treatment interruption continues to be controversial strategy in HIV care. CROI studies show mixed results.

Abstract	A variety of studies involving drug treatment interruption were presented at the 13th Conference on Retroviruses and Opportunistic Infections (CROI), held in Denver, CO, in February, and their conclusions were mixed. Some had results that provided reason to consider treatment interruption a possible strategy, and others found that it could place patients at greater risk for disease progression.
Authors
Journal	AIDS alert (AIDS Alert) Vol. 21 Issue 3 Pg. 13-6 (Mar 2006) ISSN: 0887-0292 [Print] United States
PMID	17378059 (Publication Type: Congress, Newspaper Article)
Chemical References	Anti-HIV Agents
Topics	Anti-HIV Agents (administration & dosage) CD4 Lymphocyte Count Drug Administration Schedule HIV Infections (drug therapy) Humans Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!